| Lot Release Number |
2021-06-23-0291
|
| FDA Registered Product/Generic Name |
ATEZOLIZUMAB
|
| Brand Name |
TECENTRIQ
|
| Dosage Strength |
60 mg/mL (1200 mg/20 mL)
|
| Dosage Form |
CONCENTRATE FOR SOLUTION FOR INFUSION
|
| Registration Number |
BR-1280
|
| Batch/Lot Number |
H0273
|
| Packaging Lot |
Packaging Lot (Box & Vial): 0370G142; (Diluent): 0700S4017 & 0700S4018
|
| Product Expiration Date |
30 November 2022
|
| Issuance Date |
24 June 2021
|